Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: An ex vivo study in humans

Journal of Nutritional Biochemistry

Volumn 11, Issue 4, 2000, Pages 216-222

  Miura, Yukiko ^a   Chiba, Tsuyoshi ^a   Miura, Shinji ^a   Tomita, Isao ^b   Umegaki, Keizo ^c   Ikeda, Masahiko ^a   Tomita, Takako ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Shizuoka Sangyo University   (Japan)

^c NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Ex vivo; Green tea polyphenols; Humans; Lag time; LDL oxidation; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; POLYPHENOL; POLYPHENON E; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID OXIDATION; MALE; NORMAL HUMAN; TEA; VOLUNTEER;

EID: 0034071342     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-2863(00)00068-1     Document Type: Article

References (44)

1. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radical Bio. Med. 20:1996;707-727.
2. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
3. Esterbauer H., Jurgens G., Quehenberger O., Koller E. Autoxidation of human low density lipoprotein loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes . J. Lipid Res. 28:1987;495-509.
4. Gey L.F., Brubacher G.B., Stahelin H.B. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am. J. Clin. Nutr. 45:1987;1368-1377.
5. Hertog M.G.L., Feskens E.J.M., Hollman P.C.H., Karan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease the Zutphen Elderly Study . Lancet. 342:1993;1007-1011.
6. Knekt P., Jarvinen R., Reunanen A., Maatela J. Flavonoid intake and coronary mortality in Finland a cohort study . Brit. Med. J. 312:1996;478-481.
7. Hertog M.G.L., Feskens E.J.M., Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet. 349:1997;699.
8. Rimm E.B., Katan M.B., Ascherio A., Stampfer M.J., Willett W.C. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann. Intern. Med. 125:1996;384-389.
9. Stensvold I., Tverdal A., Solvoll K., Foss O.P. Tea consumption. Relationship to cholesterol, blood pressure, and coronary and total mortality. Prev. Med. 21:1992;546-553.
10. Brown C.A., Bolton-Smith C., Woodward M., Tunstall-Pedoe H. Coffee and tea consumption and the prevalence of coronary heart disease in men and women results from the Scottish Heart Health Study . J. Epidemiol. Commun. H. 47:1993;171-175.
11. Sesso H.D., Gaziano J.M., Buring J.E., Hennekens C.H. Coffee and tea intake and the risk of myocardial infarction. Am. J. Epidemiol. 149:1999;162-167.
12. Hertog M.G., Sweetnam P.M., Fehily A.M., Elwood P.C., Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men the Caerphilly Study . Am. J. Clin. Nutr. 65:1997;1489-1494.
13. Graham H.N. Green tea composition, consumption, and polyphenol chemistry. Prev. Med. 21:1992;334-350.
14. Yoshino K., Tomita I., Sano M., Oguni I., Hara Y., Nakano M. Effects of long term dietary supplement of tea polyphenols on lipid peroxide levels in rats. Age. 17:1994;79-85.
15. Jain A.J., Shimoi K., Nakamura Y., Kada T., Hara Y., Tomita I. Crude tea extracts decrease the mutagenic activity of N-methyl-N′-nitro-N-nitrosoguanidine in vitro and in intragastric tract of rats. Mutat. Res. 210:1989;1-8.
16. Nakamura, Y., Kawase, I., Harada, S., Matsuda, M., Honma, T., and Tomita, I. (1997). Antitumor promoting effects of tea aqueous non-dialysates in mouse epidermal JB6 cells. In: Food Factors for Cancer Prevention (H. Ohigashi, T. Osawa, J. Terao, S. Watanabe, and T. Yoshikawa, eds.), pp.138-141, Springer Verlag, Tokyo, Japan.
17. 2+ mediated oxidative modification of low density lipoprotein. Biol. Pharm. Bull. 17:1994;1567-1572.
18. 2+-mediated oxidative modification of low density lipoprotein. Biol. Pharm. Bull. 18:1995;1-4.
19. Chung B.H., Segrest J.P., Ray M.J., Brunzell J.D., Hokanson J.E., Krauss R.M., Beandrie K., Cone J.T. Single vertical spin density gradient ultracentrifugation. Method. Enzymol. 128:1986;181-209.
20. Lee M.J., Wang Z.Y., Li H., Chen L., Sun Y., Gobbo S., Balentine D.A., Yang C.S. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidem. Biomark. 4:1995;393-399.
21. Omaye S.T., Turnbull J.D., Sauberlich H.E. Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Method. Enzymol. 62:1979;3-11.
22. Ueda T., Igarashi O. New solvent system for extraction of tocopherols from biological specimens for HPLC determination and the evaluation of 2,2,5,7,8-penta methyl 6-chromanol as an internal standard. J. Micronutr. Anal. 3:1987;185-198.
23. Stacewicz-Sapuntzakis M., Bowen P., Kendall J., Burgess M. Simultaneous determination of serum retinal and various carotenoids. J. Micronutr. Anal. 3:1987;27-45.
24. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:1976;212-216.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
26. Princen H.M., van Duyvenvoorde W., Buytenhek R., van der Laarse A., van Poppel G., Gevers Leuven L.A., van Hinsbergh V.W. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscl. Throm. Vas. 15:1995;325-333.
27. Jialal I., Fuller C.J., Huet B.A. The effect of α-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler. Thromb. Vasc. Biol. 15:1995;190-198.
28. Princen H.M., van Poppel G., Vogelezang C., Buytenhek R., Kok F.J. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. Arterioscler. Thromb. 12:1992;554-562.
29. Reaven P.D., Khouw A., Beltz W.F., Parthasarathy S., Witztum J.L. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by β-carotene. Arterioscler. Thromb. 13:1993;590-600.
30. Dugas T.R., Morel D.W., Harrison E.H. Impact of LDL carotenoid and α-tocopherol content on LDL oxidation by endothelial cells in culture. J. Lipid Res. 39:1998;999-1007.
31. Lin Y., Burri B.J., Neidlinger T.R., Muller H.G., Dueker S.R., Clifford A.J. Estimating the concentration of β-carotene required for maximal protection of low-density lipoproteins in women. Am. J. Clin. Nutr. 67:1998;837-845.
32. Steinberg F.M., Chait A. Antioxidant vitamin supplementation and lipid peroxidation in smokers. Am. J. Clin. Nutr. 68:1998;319-327.
33. Dugas T.R., Morel D.W., Harrison E.H. Dietary supplementation with β-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein. Free Radical Bio. Med. 26:1999;1059-1063.
34. Sandquist A., Briviba K., Sies H. Singlet oxygen quenching of carotenoids. Method. Enzymol. 234:1994;384-388.
35. Tikkanen M.J., Wahala K., Ojala S., Vihma V., Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc. Natl. Acad. Sci. USA. 95:1998;3106-3110.
36. Kondo K., Hirano R., Matsumoto A., Igarashi O., Itakura H. Inhibition of LDL oxidation by cocoa. Lancet. 348:1996;1514.
37. Fuhrman B., Buch S., Vaya J., Belinky P.A., Coleman R., Hayak T., Aviram M. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice . Am. J. Clin. Nutr. 66:1997;267-275.
38. de Rijke Y.B., Demacker P.N., Assen N.A., Sloots L.M., Katan M.B., Stalenhoef A.F. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. Am. J. Clin. Nutr. 63:1996;329-334.
39. Serafini M., Ghiselli A., Ferro-Luzzi A. In vivo antioxidant effect of green and black tea in man. Eur. J. Clin. Nutr. 50:1996;28-32.
40. van het Hof K.H., de Boer H.S., Wiseman S.A., Lien N., Westrate J.A., Tijburg L.B. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 66:1997;1125-1132.
41. Princen H.M., van Duyvenvoorde W., Buytenhek R., Blonk C., Tijburg L.B., Langius J.A., Meinders A.E., Pijl H. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscl. Throm. Vas. 18:1998;833-841.
42. Ishikawa T., Suzukawa M., Ito T., Yoshida H., Ayaori M., Nishiwaki M., Yonemura A., Hara Y. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am. J. Clin. Nutr. 66:1997;261-266.
43. Tomita I., Sano M., Sasaki K., Miyase T. Tea catechin (EGCg) and its metabolites as bioantioxidants. Shibamoto T., Terao J., Osawa T. ACS Symposium Series No 701 Functional Foods for Disease Prevention I. Fruits, Vegetables, and Teas . 1998;209-216 The American Chemical Society, Washington, DC, USA.
44. Miura, Y., Chiba, T., Tomita, I., Ikeda, M., and Tomita, T. (1998). Antiatherogenic effects of tea catechins in apoE-deficient mice [abstract]. Domyakukouka(Japanese) 25(suppl), 109.